Report Detail
Global CGRP Antagonists Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4565013 |
- 07 November, 2023 |
- Global |
- 97 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global CGRP Antagonists market size was valued at USD 2935.6 million in 2022 and is forecast to a readjusted size of USD 10000 million by 2029 with a CAGR of 19.1% during review period.
CGRP (calcitonin gene-related peptide) is a protein released around the nervous system of the brain. CGRP is widely distributed in peripheral neurons and central neurons, and its role is to participate in the process of pain transmission in the nervous system.
The CGRP (calprotectin gene-related peptide) antagonist market is a rapidly growing field focused on developing drugs to treat migraine and other neuropathic pain symptoms. These drugs reduce or prevent migraine attacks by inhibiting the effects of CGRP, providing patients with more effective pain management options. Several CGRP antagonists are already approved and in use on the market, and more new drugs are in development. Growth in this market is driven by expanding patient demand and scientific research, providing hope and an opportunity to improve the quality of life for migraine sufferers.
The Global Info Research report includes an overview of the development of the CGRP Antagonists industry chain, the market status of Hospital (Monoclonal Antibodies, CGRP Receptor Inhibitor), Clinic (Monoclonal Antibodies, CGRP Receptor Inhibitor), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CGRP Antagonists.
Regionally, the report analyzes the CGRP Antagonists markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CGRP Antagonists market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the CGRP Antagonists market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CGRP Antagonists industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, CGRP Receptor Inhibitor).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CGRP Antagonists market.
Regional Analysis: The report involves examining the CGRP Antagonists market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CGRP Antagonists market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to CGRP Antagonists:
Company Analysis: Report covers individual CGRP Antagonists manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CGRP Antagonists This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to CGRP Antagonists. It assesses the current state, advancements, and potential future developments in CGRP Antagonists areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CGRP Antagonists market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
CGRP Antagonists market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Monoclonal Antibodies
CGRP Receptor Inhibitor
Market segment by Application
Hospital
Clinic
Other
Major players covered
PFIZER INC(Biohaven)
ABBVIE INC
Amgen
Teva
Eli Lilly and Company
Lundbeck
Novartis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe CGRP Antagonists product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of CGRP Antagonists, with price, sales, revenue and global market share of CGRP Antagonists from 2018 to 2023.
Chapter 3, the CGRP Antagonists competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CGRP Antagonists breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and CGRP Antagonists market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of CGRP Antagonists.
Chapter 14 and 15, to describe CGRP Antagonists sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of CGRP Antagonists
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global CGRP Antagonists Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Monoclonal Antibodies
- 1.3.3 CGRP Receptor Inhibitor
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global CGRP Antagonists Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
- 1.5 Global CGRP Antagonists Market Size & Forecast
- 1.5.1 Global CGRP Antagonists Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global CGRP Antagonists Sales Quantity (2018-2029)
- 1.5.3 Global CGRP Antagonists Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 PFIZER INC(Biohaven)
- 2.1.1 PFIZER INC(Biohaven) Details
- 2.1.2 PFIZER INC(Biohaven) Major Business
- 2.1.3 PFIZER INC(Biohaven) CGRP Antagonists Product and Services
- 2.1.4 PFIZER INC(Biohaven) CGRP Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 PFIZER INC(Biohaven) Recent Developments/Updates
- 2.2 ABBVIE INC
- 2.2.1 ABBVIE INC Details
- 2.2.2 ABBVIE INC Major Business
- 2.2.3 ABBVIE INC CGRP Antagonists Product and Services
- 2.2.4 ABBVIE INC CGRP Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 ABBVIE INC Recent Developments/Updates
- 2.3 Amgen
- 2.3.1 Amgen Details
- 2.3.2 Amgen Major Business
- 2.3.3 Amgen CGRP Antagonists Product and Services
- 2.3.4 Amgen CGRP Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Amgen Recent Developments/Updates
- 2.4 Teva
- 2.4.1 Teva Details
- 2.4.2 Teva Major Business
- 2.4.3 Teva CGRP Antagonists Product and Services
- 2.4.4 Teva CGRP Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Teva Recent Developments/Updates
- 2.5 Eli Lilly and Company
- 2.5.1 Eli Lilly and Company Details
- 2.5.2 Eli Lilly and Company Major Business
- 2.5.3 Eli Lilly and Company CGRP Antagonists Product and Services
- 2.5.4 Eli Lilly and Company CGRP Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Eli Lilly and Company Recent Developments/Updates
- 2.6 Lundbeck
- 2.6.1 Lundbeck Details
- 2.6.2 Lundbeck Major Business
- 2.6.3 Lundbeck CGRP Antagonists Product and Services
- 2.6.4 Lundbeck CGRP Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Lundbeck Recent Developments/Updates
- 2.7 Novartis
- 2.7.1 Novartis Details
- 2.7.2 Novartis Major Business
- 2.7.3 Novartis CGRP Antagonists Product and Services
- 2.7.4 Novartis CGRP Antagonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Novartis Recent Developments/Updates
3 Competitive Environment: CGRP Antagonists by Manufacturer
- 3.1 Global CGRP Antagonists Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global CGRP Antagonists Revenue by Manufacturer (2018-2023)
- 3.3 Global CGRP Antagonists Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of CGRP Antagonists by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 CGRP Antagonists Manufacturer Market Share in 2022
- 3.4.2 Top 6 CGRP Antagonists Manufacturer Market Share in 2022
- 3.5 CGRP Antagonists Market: Overall Company Footprint Analysis
- 3.5.1 CGRP Antagonists Market: Region Footprint
- 3.5.2 CGRP Antagonists Market: Company Product Type Footprint
- 3.5.3 CGRP Antagonists Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global CGRP Antagonists Market Size by Region
- 4.1.1 Global CGRP Antagonists Sales Quantity by Region (2018-2029)
- 4.1.2 Global CGRP Antagonists Consumption Value by Region (2018-2029)
- 4.1.3 Global CGRP Antagonists Average Price by Region (2018-2029)
- 4.2 North America CGRP Antagonists Consumption Value (2018-2029)
- 4.3 Europe CGRP Antagonists Consumption Value (2018-2029)
- 4.4 Asia-Pacific CGRP Antagonists Consumption Value (2018-2029)
- 4.5 South America CGRP Antagonists Consumption Value (2018-2029)
- 4.6 Middle East and Africa CGRP Antagonists Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global CGRP Antagonists Sales Quantity by Type (2018-2029)
- 5.2 Global CGRP Antagonists Consumption Value by Type (2018-2029)
- 5.3 Global CGRP Antagonists Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global CGRP Antagonists Sales Quantity by Application (2018-2029)
- 6.2 Global CGRP Antagonists Consumption Value by Application (2018-2029)
- 6.3 Global CGRP Antagonists Average Price by Application (2018-2029)
7 North America
- 7.1 North America CGRP Antagonists Sales Quantity by Type (2018-2029)
- 7.2 North America CGRP Antagonists Sales Quantity by Application (2018-2029)
- 7.3 North America CGRP Antagonists Market Size by Country
- 7.3.1 North America CGRP Antagonists Sales Quantity by Country (2018-2029)
- 7.3.2 North America CGRP Antagonists Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe CGRP Antagonists Sales Quantity by Type (2018-2029)
- 8.2 Europe CGRP Antagonists Sales Quantity by Application (2018-2029)
- 8.3 Europe CGRP Antagonists Market Size by Country
- 8.3.1 Europe CGRP Antagonists Sales Quantity by Country (2018-2029)
- 8.3.2 Europe CGRP Antagonists Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific CGRP Antagonists Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific CGRP Antagonists Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific CGRP Antagonists Market Size by Region
- 9.3.1 Asia-Pacific CGRP Antagonists Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific CGRP Antagonists Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America CGRP Antagonists Sales Quantity by Type (2018-2029)
- 10.2 South America CGRP Antagonists Sales Quantity by Application (2018-2029)
- 10.3 South America CGRP Antagonists Market Size by Country
- 10.3.1 South America CGRP Antagonists Sales Quantity by Country (2018-2029)
- 10.3.2 South America CGRP Antagonists Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa CGRP Antagonists Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa CGRP Antagonists Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa CGRP Antagonists Market Size by Country
- 11.3.1 Middle East & Africa CGRP Antagonists Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa CGRP Antagonists Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 CGRP Antagonists Market Drivers
- 12.2 CGRP Antagonists Market Restraints
- 12.3 CGRP Antagonists Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of CGRP Antagonists and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of CGRP Antagonists
- 13.3 CGRP Antagonists Production Process
- 13.4 CGRP Antagonists Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 CGRP Antagonists Typical Distributors
- 14.3 CGRP Antagonists Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on CGRP Antagonists. Industry analysis & Market Report on CGRP Antagonists is a syndicated market report, published as Global CGRP Antagonists Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of CGRP Antagonists market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
